The Medicare prescription drug plan market appears to be under a lot of stress. And taxpayers are forking over record amounts ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

After years of counseling families through loss, I am still moved by their strength. I carry with me Eleanor’s prayer, ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too ...

Trump's order to block state AI laws could help the tech industry but hurt health systems looking to adopt AI safely, and ...

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...